Establishment Labs Holdings Inc. (ESTA) vs Immunome, Inc. (IMNM)

A side-by-side comparison of Establishment Labs Holdings Inc. and Immunome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ESTA vs IMNM

growth of $100 · dividends reinvested · last 6y
ESTA +251.0% (+23.3%/yr)IMNM +57.4% (+7.9%/yr)ESTA compounded faster over this window
0100200300400500Start $100202120222023202420252026$351$157
ESTA IMNM

ESTA vs IMNM: by the numbers

  • •IMNM is the larger company ($1.99B vs $1.94B market cap).
  • •Both run net losses; ESTA's is the smaller (-15.82% vs -3059.99% net margin).

Metrics side by side

Valuation

MetricESTAIMNM
P/S ratio7.89N/A
P/B ratio89.763.78

Profitability

MetricESTAIMNM
Gross margin70.49%57.43%
Operating margin-18.48%-3084.76%
Net margin-15.82%-3059.99%
ROE-179.99%-48.43%
ROIC-6.53%-51.06%

Growth (annualized)

MetricESTAIMNM
Revenue CAGR (5Y)17.02%N/A
Total return CAGR (5Y)-1.56%2.88%

Frequently asked

How have ESTA and IMNM total returns compared?
Over the past 5 years, ESTA delivered -1.56% and IMNM delivered 2.88% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.